Localization of shapes using statistical models and stochastic optimization

In this paper, we present a new model for deformations of shapes. A pseudo-likelihood is based on the statistical distribution of the gradient vector field of the gray level. The prior distribution is based on the Probabilistic Principal Component Analysis (PPCA). We also propose a new model based on mixtures of PPCA that is useful in the case of greater variability in the shape. A criterion of global or local object specificity based on a preliminary color segmentation of the image, is included into the model. The localization of a shape in an image is then viewed as minimizing the corresponding Gibbs field. We use the Exploration/Selection (E/S) stochastic algorithm in order to find the optimal deformation. This yields a new unsupervised statistical method for localization of shapes. In order to estimate the statistical parameters for the gradient vector field of the gray level, we use an Iterative Conditional Estimation (ICE) procedure. The color segmentation of the image can be computed with an Exploration/Selection/Estimation (ESE) procedure.     

可以进一步取代人造丝的新型聚酯增强材料（二）

可以进一步取代人造丝的新型聚酯增强材料（二）     

Hybrid film of chemically modified graphene and vapor-phase-polymerized PEDOT for electronic nose applications

A hybrid of graphene and conducting polymer holds great potential as the active materials for high performance chemical sensor application. In this work, a thin hybrid film of reduced graphene oxide (RG-O) and poly(3,4-ethylenedioxythiophene) (PEDOT) was fabricated by means of vapor phase polymerization and explored as active material for chemical sensors. The chemical sensors based on hybrid film of RG-O and PEDOT are capable of detecting electrical signals caused by the absorption of trace levels of different analyte vapors with high sensitivity, selectivity and fast response.     

Identification of Reference Genes for RT-qPCR Data Normalization in Cannabis sativa Stem Tissues

Gene expression profiling via quantitative real-time PCR is a robust technique widely used in the life sciences to compare gene expression patterns in, e.g., different tissues, growth conditions, or after specific treatments. In the field of plant science, real-time PCR is the gold standard to study the dynamics of gene expression and is used to validate the results generated with high throughput techniques, e.g., RNA-Seq. An accurate relative quantification of gene expression relies on the identification of appropriate reference genes, that need to be determined for each experimental set-up used and plant tissue studied. Here, we identify suitable reference genes for expression profiling in stems of textile hemp (Cannabis sativa L.), whose tissues (isolated bast fibres and core) are characterized by remarkable differences in cell wall composition. We additionally validate the reference genes by analysing the expression of putative candidates involved in the non-oxidative phase of the pentose phosphate pathway and in the first step of the shikimate pathway. The goal is to describe the possible regulation pattern of some genes involved in the provision of the precursors needed for lignin biosynthesis in the different hemp stem tissues. The results here shown are useful to design future studies focused on gene expression analyses in hemp.     

表现出良好带束层边缘粘合性能的冠带层新材料

本文介绍了加工助剂莱茵塑分T和增塑剂A在全钢载重子午线轮胎胎面配方中的胶料性能对比，并着重考察了对胎面挤出性能和外胎性能的影响。试验结果表明，使用加工助剂能降低胎面的挤出温度，提高胎面的挤出速度；两种加工助剂相比，含莱茵塑分T的胶料老化性能、疲劳性能和分散性以及胎面挤出温度和断面气孔情况均比增塑剂A好；外胎的耐久试验均超过国家标准。     

可以进一步取代人造丝的新型聚酯增强材料（一）

可以进一步取代人造丝的新型聚酯增强材料（一）     

Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aigu?s Myéloblastiques (GOELAM)

Three intensive consolidation strategies are currently proposed to younger adults with acute myeloid leukemia (AML) in first complete remission (CR): allogeneic or autologous bone marrow transplantation (BMT) and intensive consolidation chemotherapy (ICC). Patients aged 15 to 50 years with de novo AML received an induction treatment with 7 days of cytarabine and either idarubicin or rubidazone. After achievement of a CR, patients up to the age of 40 and having an HLA-identical sibling were assigned to undergo an allogeneic BMT. All the other patients received a first course of ICC with high-dose cytarabine and the same anthracycline as for induction. They were then randomly assigned to either receive a second course of ICC with amsacrine and etoposide or a combination of busulfan and cyclosphosphamide followed by an unpurged autologous BMT. Of 517 eligible patients, 367 had a CR, but only 219 (59.5%) actually received the planned intensive postremission treatment (73 allogeneic BMT, 75 autologous BMT, and 71 ICC). With a median follow-up of 62 months, the 4-year disease-free survival (DFS) of the 367 patients in CR was 39.5%. The 4-year overall survival (OS) of the 517 eligible patients was 40.5%. In multivariate analysis, DFS and OS were influenced only by the initial white blood cell count and by the French-American-British classification. The type of postremission therapy had no significant impact on the outcome. There was no difference in the 4-year DFS and OS between 88 patients for whom an allogeneic BMT was scheduled (respectively, 44% and 53%) and 134 patients of the same age category and without an HLA-identical sibling (respectively, 38% and 53%). Similarly, there was no difference in the outcome between autologous BMT and ICC. The 4-year DFS was 44% for the 86 patients randomly assigned to autologous BMT and 40% for the 78 patients assigned to ICC (P = .41). The 4-year OS was similar in the two groups (50% v 54.5%, P = .72). The median duration of hospitalization and thrombocytopenia were longer after autologous BMT (39 v 32 days, P = .006, and 109.5 v 18.5 days, P = .0001, respectively). After a first course of ICC, a second course of chemotherapy is less myelotoxic than an unpurged autologous BMT but yields comparable DFS and OS rates.     

Automatic generation of noise-free time-activity curve with gated blood-pool emission tomography using deformation of a reference curve

This paper describes a new method for assessing clinical parameters from a noisy regional time-activity curve (TAC) in tomographic gated blood-pool ventriculography. This method is based on a priori knowledge on the shape of a TAC, and shape approximation. The rejection method was used to generate different random Poisson deviates, covering standard count levels, of six representative TACs in order to test and compare the proposed method with harmonic and multiharmonic reconstruction methods. These methods were compared by evaluating four clinical parameters: time of end systole, amplitude, peak ejection and filling rates. Overall, the accuracy of assessment of these parameters was found to be better with the method described in this paper than with standard multiharmonic fits.